Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury
Matthieu Legrand(University of California, San Francisco), Romain Sonneville(Université Claude Bernard Lyon 1), Matthieu Resche‐Rigon(Inserm), Marie-Céline Fournier(Inserm), Qin Lü(Shanghai Jiao Tong University), Samir Jaber(Inserm), Alain Cariou(Hôpital Cochin), Étienne Gayat(Inserm), Michaël Darmon(Inserm), Xavier Monnet(Bicêtre Hospital), Benjamin G. Chousterman(Inserm), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Marc Léone(Hôpital Nord), Jean‐Yves Lefrant(Université de Montpellier), Antoine Vieillard‐Baron(Inserm), Nicolas Deye(Inserm), Pierre François Laterre(Université Paris-Sud), Alexa Hollinger(University of Basel), Bertrand Guidet(Sorbonne Université)
Cited by 92
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k